chikungunya
viru
chikv
reemerg
caus
unpreced
outbreak
asia
africa
sinc
estim
number
case
exce
million
thousand
infect
travel
return
europ
usa
sinc
chikv
gener
caus
fever
resolv
within
sever
day
maculopapular
rash
characterist
arthralgia
extrem
pain
may
persist
month
recent
outbreak
also
sever
clinic
manifest
report
occasion
neurolog
complic
even
death
usual
elderli
patient
underli
condit
newborn
licens
vaccin
specif
antivir
therapi
current
avail
chikv
alphaviru
kb
positivestrand
rna
genom
contain
two
open
read
frame
orf
orf
encod
nonstructur
polyprotein
latter
result
translat
readthrough
opal
termin
codon
present
end
nonstructur
protein
nsp
code
sequenc
chikv
isol
assum
chikv
follow
typic
alphaviru
life
cycl
proteolyt
process
nonstructur
polyprotein
proteas
domain
ultim
lead
releas
nsp
precursor
possess
varieti
function
enzymat
activ
includ
proteas
helicas
methyltransferas
rnadepend
rna
polymeras
rdrp
activ
drive
chikv
replic
addit
replic
genom
rna
chikv
also
transcrib
subgenom
sg
rna
encod
precursor
polyprotein
process
viral
cellular
proteas
structur
protein
c
chikv
nsp
presum
togeth
host
factor
assembl
replic
transcript
complex
rtc
associ
membran
structur
deriv
plasma
membran
andor
endosom
observ
alphavirus
chikv
strain
emerg
outbreak
acquir
mutat
envelop
glycoprotein
facilit
transmiss
viru
via
new
vector
asian
tiger
mosquito
aed
albopictu
consequ
dramat
increas
epidem
potenti
chikv
later
studi
suggest
recent
indian
indian
ocean
epidem
emerg
separ
result
least
three
independ
event
converg
evolut
eastcentralsouth
african
lineag
strain
differ
geograph
region
ultim
led
emerg
strain
substitut
recent
amino
acid
posit
epistat
interact
also
shown
play
import
role
emerg
new
chikv
variant
even
replac
endem
strain
circul
asia
decad
aed
albopictu
also
thrive
temper
climat
geograph
distribut
rapidli
expand
past
decad
part
southern
europ
larg
area
usa
invad
mosquito
provid
import
case
chikv
compet
mosquito
vector
thu
pave
road
outbreak
nonendemicarea
usa
europ
inde
autochthon
infect
report
itali
franc
recent
ongo
chikv
outbreak
character
rapid
geograph
spread
high
number
infect
peopl
high
morbid
emphas
need
gain
insight
replic
cycl
import
human
pathogen
infecti
cdna
clone
virus
becom
invalu
tool
allow
revers
genet
studi
elucid
contribut
specif
amino
acid
rna
structur
viraemia
virul
antigen
replic
kinet
interact
host
factor
adapt
new
vector
mani
aspect
viral
life
cycl
use
cdna
clone
also
instrument
mechan
action
studi
pinpoint
viral
target
antivir
compound
select
genotyp
compoundresist
virus
follow
revers
engin
identifi
mutat
assess
individu
phenotyp
contribut
resist
final
gener
cdna
clone
report
virus
like
express
green
fluoresc
protein
gfp
greatli
facilit
high
throughput
screen
eg
antivir
compound
host
factor
affect
replic
sever
chikv
cdna
clone
construct
past
except
west
african
lineag
strain
strain
isol
mosquito
base
clinic
isol
infect
human
natur
isol
expect
evolv
specif
characterist
term
sequenc
virul
virushost
interact
result
specif
select
pressur
within
infect
host
tissu
possibl
also
subsequ
passag
cell
cultur
intrahost
evolut
quasispeci
divers
expect
substanti
especi
compar
rel
low
level
interhost
variat
consensu
sequenc
chikv
genom
isol
differ
host
align
low
level
interhost
variat
typic
trait
arbovirus
due
evolutionari
constraint
impos
altern
replic
vertebr
arthropod
host
recent
studi
distantli
relat
ross
river
viru
inde
report
high
level
intrahost
divers
exist
chikv
molecular
clone
consid
repres
singl
individu
genom
fragment
sever
individu
genom
whole
spectrum
virus
present
chikv
quasispeci
popul
shape
intrahost
evolut
probabl
complex
set
environment
factor
contrast
deposit
chikv
genom
sequenc
repres
consensu
master
sequenc
viral
quasispeci
popul
obtain
viru
term
virul
sensit
antivir
compound
chikvhost
interact
expect
gener
characterist
chikv
strain
circul
outbreak
construct
complet
synthet
chikv
cdna
clone
base
consensu
sequenc
align
genom
recent
isol
new
infecti
clone
chikv
leiden
synthet
variant
express
egfp
report
gene
control
duplic
subgenom
promot
chikv
creat
custom
dna
synthesi
properti
replic
cycl
new
synthet
virus
character
detail
comparison
field
isol
chikv
outbreak
itali
demonstr
similar
characterist
sensit
number
antivir
compound
compar
clinic
isol
compound
test
similar
antivir
activ
natur
isol
experi
also
identifi
novel
inhibitor
chikv
replic
studi
describ
detail
character
chikv
replic
cycl
molecular
level
demonstr
new
synthet
infecti
clonederiv
viru
use
repres
tool
gain
insight
replic
cycl
chikv
interact
host
mode
action
antivir
compound
aid
develop
antivir
strategi
import
human
pathogen
vero
ae
albopictu
cell
maintain
dulbecco
modifi
eagl
medium
dmem
lonza
supplement
fetal
calf
serum
fc
paa
mm
lglutamin
iuml
penicillin
streptomycin
cell
grown
presenc
blasticidin
paa
medium
supplement
nonessenti
amino
acid
lonza
cell
cultur
glasgow
modifi
eagl
medium
gibco
supplement
fc
mm
hepe
ph
tryptos
phosphat
broth
gibco
antibiot
mammalian
cell
line
grown
cell
chikv
strain
genbank
access
number
isol
ae
albopictu
outbreak
ravenna
itali
passag
twice
cell
chikv
genbank
isol
erasmu
medic
center
rotterdam
serum
infect
travel
return
indonesia
passag
twice
vero
cell
work
stock
chikv
routin
produc
vero
cell
typic
yield
titer
pfuml
infect
perform
eagl
minim
essenti
medium
emem
lonza
mm
hepe
lonza
supplement
fc
lglutamin
antibiot
h
inoculum
replac
fresh
cultur
medium
procedur
live
chikv
perform
biosafeti
level
facil
leiden
univers
medic
center
cdna
clone
synthet
chikv
strain
contain
duplic
subgenom
promot
express
egfp
report
gene
design
silico
describ
result
section
three
dna
fragment
togeth
form
cdna
copi
chikv
chemic
synthes
geneart
germani
use
standard
clone
techniqu
fragment
assembl
clone
ascinoti
site
vector
plasmid
origin
polylink
replac
one
ascincoiecorvxhoinoti
site
result
plasmid
contain
genom
cdna
chikv
directli
downstream
promot
follow
uniqu
spei
linear
site
dna
linear
prior
vitro
transcript
wild
type
synthet
construct
made
delet
bp
egfpcontain
saci
fragment
fig
third
variant
duplic
subgenom
promot
multipl
clone
site
behind
subgenom
promot
allow
introduct
eg
report
gene
gener
remov
bp
asisipaci
fragment
construct
verifi
sequenc
rna
transcrib
plasmid
promot
use
ampliscrib
high
yield
transcript
kit
epicent
rna
cap
structur
analog
neb
templat
dna
linear
spei
reaction
templat
dna
digest
dnasei
rna
purifi
precipit
licl
ambion
concentr
vitro
transcrib
rna
determin
nanodrop
spectrophotomet
thermo
scientif
integr
check
agaros
gel
electrophoresi
cell
electropor
rna
use
program
amaxa
nucleofector
kit
lonza
accord
manufactur
instruct
electropor
cell
plate
cluster
incub
medium
use
chikv
infect
experi
chikv
rna
isol
virion
use
qiaamp
viral
rna
mini
kit
four
overlap
amplicon
gener
twostep
revers
transcriptas
rt
pcr
first
step
cdna
synthes
use
revertaid
h
minu
revers
transcriptas
fermenta
primer
gactgcagatgcccgccatt
cgctcggtccaggcaactct
cgtggtgtttgccaacaggc
cgccgttttttttttttttttttttttttt
second
step
pcr
product
gener
use
combin
primer
atggctgcgtgagacacacg
tgcacccaagtgtaccacaa
caggagagtgcatccatggc
gaatgcgcgcagatacccgt
result
rtpcr
product
purifi
directli
sequenc
ng
templat
use
bigdy
termin
cycl
sequenc
kit
appli
biosystem
genet
analyz
automat
sequenc
appli
biosystem
pcr
condit
primer
sequenc
avail
upon
request
viral
titer
determin
plaqu
assay
vero
cell
sixwel
cluster
contain
confluent
monolay
vero
cell
incub
volum
serial
dilut
chikvcontain
sampl
incub
inoculum
replac
ml
dmem
contain
avicel
fmc
biopolym
fc
mm
hepe
antibiot
incub
monolay
fix
formaldehyd
pb
plaqu
visual
crystal
violet
stain
infecti
center
assay
serial
dilut
electropor
cell
ad
cluster
alreadi
contain
monolay
cell
per
well
incub
dmemavicel
overlay
appli
cell
incub
h
plaqu
visual
describ
total
rna
isol
cell
lysi
ml
mm
trishcl
ph
mm
licl
mm
edta
mm
dtt
wv
lithium
dodecyl
sulfat
proteinas
k
acid
phenol
ambion
extract
rna
precipit
isopropanol
wash
ethanol
dissolv
mm
sodium
citrat
ph
sampl
contain
rna
cell
mix
volum
formamid
formaldehyd
glycerol
mm
mop
ph
mm
naac
mm
edta
sd
bromophenol
blue
denatur
min
rna
separ
denatur
formaldehydeagaros
gel
use
mop
buffer
system
describ
rna
molecul
detect
direct
hybrid
dri
gel
oligonucleotid
essenti
describ
previous
positivestrand
genom
subgenom
chikv
rna
visual
probe
complementari
end
genom
negativestrand
rna
detect
probe
complementari
end
minu
strand
ribosom
rna
load
control
detect
oligonucleotid
probe
probe
pmol
label
atp
perkinelm
reaction
use
u
polynucleotid
kinas
invitrogen
suppli
forward
reaction
buffer
invitrogen
prehybrid
h
hybrid
overnight
done
sspe
nacl
mm
mm
edta
ph
denhardt
solut
sd
mgml
homomix
hybrid
gel
wash
twice
sspe
sd
expos
storag
phosphor
screen
scan
scanner
ge
healthcar
quantif
rna
level
done
quantiti
one
biorad
correct
load
variat
made
base
quantiti
ribosom
rna
lane
result
two
three
independ
experi
quantifi
one
repres
experi
shown
figur
total
protein
sampl
prepar
lyse
cell
ml
laemmli
sampl
buffer
mm
trishcl
ph
glycerol
sd
mm
dtt
mgml
bromophenol
blue
protein
separ
sdspage
polyacrylamid
gel
transfer
hybondlfp
membran
ge
healthcar
semidri
blot
block
casein
sigma
pb
pbst
membran
incub
overnight
rabbit
antisera
chikv
rais
use
peptid
eveprqvtpndhan
rais
use
peptid
assrsnfeklrgpv
pbst
casein
mous
monoclon
antibodi
sigma
transferrin
receptor
zyme
use
detect
load
control
biotinconjug
dako
dako
jackson
use
fluoresc
detect
primari
antibodi
scanner
ge
healthcar
variou
time
point
post
infect
approxim
chikvinfect
mockinfect
cell
cluster
incub
medium
incorpor
allow
proceed
minut
total
rna
isol
analyz
denatur
agaros
gel
describ
fluorograph
detect
rna
gel
soak
methanol
hour
one
chang
incub
methanol
least
hour
incub
milliq
minut
gel
dri
fuji
rx
film
place
top
film
develop
day
exposur
scan
biorad
densitomet
check
equal
sampl
load
gel
hybrid
ribosom
rnaspecif
probe
describ
addit
incorpor
rna
quantifi
analyz
sampl
isol
total
rna
liquid
scintil
counter
beckman
ls
ic
control
sampl
cellular
transcript
inhibit
ad
actinomycin
sigma
final
concentr
variou
time
point
post
infect
approxim
chikvinfect
mockinfect
cell
cluster
starv
dmem
lack
lmethionin
lcystein
invitrogen
min
subsequ
incub
easytag
express
protein
label
mix
perkinelm
min
total
protein
sampl
analyz
sdspage
describ
gel
stain
coomassi
check
equal
sampl
load
protein
detect
dri
gel
expos
storag
phosphor
screen
scan
day
later
scanner
ge
healthcar
chikv
mockinfect
vero
cell
grown
coverslip
fix
paraformaldehyd
pb
quench
mm
glycin
pb
cell
permeabil
triton
pb
min
coverslip
incub
primari
antibodi
dilut
pb
fc
h
doublestrand
rna
detect
dilut
mous
monoclon
antibodi
english
scientif
consult
chikv
visual
dilut
polyclon
rabbit
antiserum
detect
primari
antibodi
done
jackson
nuclei
stain
hoechst
coverslip
mount
prolong
invitrogen
analyz
use
mot
plu
fluoresc
microscop
axiocam
hrc
camera
axiovis
softwar
zeiss
mous
monoclon
antibodi
rais
chikv
particl
strain
izsler
brescia
itali
heatinactiv
min
twofold
serial
dilut
neutral
monoclon
antibodi
nonneutr
control
antibodi
incub
equal
volum
medium
contain
pfu
chikv
mixtur
incub
min
transfer
cluster
contain
vero
cell
per
well
incub
day
well
fix
formaldehyd
cpe
detect
stain
crystal
violet
chloroquin
ribavirin
dissolv
pb
cyclosporin
dissolv
dmso
mycophenol
acid
dissolv
ethanol
compound
obtain
sigma
cpe
reduct
assay
cluster
vero
cellswel
incub
pfu
viru
per
well
correspond
multipl
infect
moi
serial
dilut
compound
medium
well
without
cell
uninfect
cell
infect
untreat
cell
infect
cell
treat
solvent
alon
includ
control
four
day
postinfect
cell
viabil
assess
use
celltit
aqueou
nonradioact
cell
prolifer
assay
promega
cpe
reduct
experi
ribavirin
done
cell
similar
way
except
viabil
assess
day
post
infect
egfp
report
gene
assay
vero
cellswel
black
plate
infect
chikv
moi
incub
medium
contain
compound
cell
fix
paraformaldehyd
pb
egfp
express
quantifi
use
berthold
mithra
lb
plate
reader
excit
emiss
wavelength
nm
respect
fluoresc
well
contain
mockinfect
cell
use
correct
background
signal
valu
calcul
graphpad
prism
use
nonlinear
regress
model
anim
experi
describ
paper
carri
facil
erasmu
medic
center
accord
dutch
guidelin
anim
experiment
approv
institut
independ
anim
ethic
committe
twelveday
old
mice
inject
intraperiton
chikv
chikv
chikv
challeng
mice
monitor
daili
sign
ill
death
infect
consid
lethal
anim
reach
human
endpoint
need
euthan
viral
rna
extract
brain
sampl
use
autom
magnapur
method
total
nucleic
acid
isol
kit
roch
diagnost
netherland
accord
manufactur
instruct
quantifi
use
onestep
rtpcr
taqman
protocol
ezkit
appli
biosystem
abi
prism
detect
instrument
primer
probe
use
chikv
rna
quantif
essenti
describ
except
probe
famccaatgtcttcagcctggacaccttttamra
use
dilut
viru
suspens
known
titer
includ
make
calibr
curv
use
express
result
equival
per
gram
brain
tissu
anim
experi
describ
paper
carri
facil
erasmu
medic
center
accord
dutch
guidelin
anim
experiment
dutch
governmentapprov
independ
anim
experiment
ethic
review
committe
sticht
dec
consult
approv
anim
studi
permit
nr
genbank
access
number
fulllength
cdna
clone
respect
genbank
access
number
genom
rna
sequenc
chikv
respect
complet
genom
chikv
strain
carri
mutat
tabl
avail
genbank
time
silico
design
novemb
align
use
mafft
result
consensu
sequenc
form
basi
synthet
fulllength
cdna
clone
nucleotid
polya
tail
ad
end
consensu
sequenc
point
mutat
introduc
creat
translat
silent
saci
restrict
site
requir
clone
viru
encod
result
sequenc
term
chikv
genbank
access
variant
contain
duplic
subgenom
promot
multipl
clone
site
chikv
genbank
egfp
report
gene
chikv
genbank
also
design
egfp
report
gene
place
control
nativ
subgenom
promot
upstream
second
subgenom
promot
drive
express
viral
structur
polyprotein
configur
previous
report
result
stabl
report
gene
express
chikv
cdna
place
downstream
promot
uniqu
spei
site
linear
prior
vitro
transcript
directli
follow
polya
tail
promot
use
end
cap
transcript
gener
promot
polymeras
cap
analog
ident
end
genom
natur
occur
chikv
strain
contrast
cap
rna
gener
vitro
transcript
frequent
use
promot
contain
terminu
ie
contain
addit
g
residu
howev
exist
chikv
cdna
clone
contain
promot
also
effici
yield
infecti
viru
assum
addit
g
residu
remov
subsequ
round
replic
line
vitro
transcrib
rna
variant
plasmid
promot
replac
promot
also
yield
infecti
viru
plasmid
infecti
clone
encod
egfpexpress
report
viru
creat
assembl
chemic
synthes
dna
fragment
describ
materi
method
section
plasmid
infecti
clone
encod
synthet
wild
type
strain
chikv
plasmid
gener
delet
specif
restrict
fragment
describ
materi
method
fig
origin
align
strain
genbank
genbank
share
highest
sequenc
similar
amino
acid
differ
tabl
howev
blast
search
perform
march
three
year
design
chikv
align
retriev
complet
chikv
genom
reveal
strain
genbank
genbank
genbank
share
highest
degre
nucleotid
sequenc
ident
chikv
nucleotid
differ
respect
tabl
interestingli
indian
strain
includ
origin
align
sequenc
base
contain
mutat
tabl
howev
ident
amino
acid
level
chikv
differ
posit
posit
tabl
determin
whether
infecti
viru
could
gener
synthet
chikv
clone
vitro
transcrib
rna
electropor
cell
strong
egfp
fluoresc
readili
detect
h
transfect
chikv
rna
chikv
rna
specif
infect
approxim
rna
found
infecti
center
assay
similar
found
chikv
cdna
clone
viru
titer
cell
cultur
supernat
h
electropor
gener
rang
pfuml
lower
peak
viral
titer
obtain
infect
experi
explain
earli
time
point
harvest
fact
cell
transfect
expect
electropor
cell
uncap
chikv
rna
result
releas
infecti
viru
assess
stabil
egfp
report
express
chikv
serial
passag
moi
vero
cell
viru
harvest
passag
use
infect
vero
cell
moi
immunofluoresc
microscopi
reveal
passag
foci
still
display
robust
egfp
express
sequenc
cdna
obtain
rtpcr
amplif
rna
extract
extracellular
virion
reveal
passag
vero
cell
consensu
genom
sequenc
chikv
ident
origin
silico
design
sequenc
result
demonstr
synthet
virus
viabl
genet
stabl
abl
retain
stabl
express
report
gene
sinc
aim
use
chikv
sirna
screen
proteom
studi
identifi
host
factor
involv
replic
variou
human
cell
line
evalu
abil
support
chikv
replic
chikv
abl
product
infect
hela
cell
data
shown
infect
hela
cell
effici
cell
therefor
use
experi
cell
select
studi
support
high
level
chikv
replic
could
effici
transfect
sirna
unlik
regular
cell
adher
well
tissu
cultur
plastic
cell
stabli
express
angiotensinconvert
enzym
receptor
sarscoronaviru
express
requir
chikv
infect
cell
chosen
aforement
advantag
fact
previous
use
lab
sirna
screen
host
factor
affect
corona
arteriviru
replic
de
wild
et
al
submit
wanne
et
al
prepar
use
cell
similar
sirna
screen
chikv
alphavirus
would
allow
direct
comparison
data
set
obtain
corona
arterivirus
could
lead
identif
common
broad
spectrum
pro
antivir
host
factor
determin
whether
synthet
virus
behav
like
natur
isol
growth
kinet
vero
cell
compar
isol
chikv
outbreak
itali
fig
growth
curv
chikv
three
cell
line
found
differ
significantli
viru
titer
reach
maximum
h
post
infect
pi
peak
viru
titer
mosquito
cell
approxim
higher
mammalian
cell
chikv
replic
slightli
slower
virus
three
test
cell
line
unusu
recombin
report
virus
egfp
express
could
detect
earli
h
pi
peak
around
h
pi
plaqu
morpholog
synthet
virus
similar
fig
chikv
induc
cytopath
effect
cpe
indistinguish
natur
isol
vero
cell
earli
sign
cpe
start
appear
around
h
pi
cpe
complet
h
pi
fig
studi
chikvinduc
transcript
host
shutoff
incorpor
cellular
viral
rna
analyz
metabol
label
infect
cell
variou
time
point
post
infect
moi
strong
reduct
incorpor
rna
observ
h
pi
cell
infect
chikv
determin
liquid
scintil
count
total
rna
sampl
fig
inhibit
cellular
transcript
actinomycin
min
prior
metabol
label
h
pi
reveal
contribut
viral
rna
synthesi
total
signal
fluorograph
detect
rna
analyz
denatur
gel
also
show
decreas
cellular
transcript
cours
infect
synthesi
chikv
rna
becam
clearli
detect
h
pi
fig
transcript
shutoff
occur
around
h
pi
induc
chikv
similar
kinet
although
seem
act
slightli
faster
examin
chikvinduc
translat
shutoff
synthesi
viral
cellular
protein
cours
chikv
infect
analyz
metabol
label
infect
cell
fig
clear
shutoff
host
translat
observ
h
pi
beyond
h
pi
bulk
newli
produc
protein
appear
viral
origin
like
c
precursor
indic
fig
chikv
induc
translat
host
shutoff
similar
manner
result
obtain
shown
fig
chikv
synthet
virus
establish
noncytopath
persist
infect
mosquito
cell
character
experi
perform
vero
cell
similar
result
simplic
result
cell
shown
except
immunofluoresc
experi
done
vero
cell
suitabl
morpholog
replic
cycl
synthet
virus
character
detail
assess
whether
synthet
virus
behav
like
natur
counterpart
kinet
rna
synthesi
analyz
isol
total
rna
cell
infect
chikv
variou
time
point
post
infect
neg
positivestrand
rna
detect
hybrid
oligonucleotid
probe
fig
neg
positivestrand
rna
readili
detect
cell
infect
variou
strain
start
h
pi
negativestrand
rna
less
abund
posit
strand
easili
detect
rel
earli
infect
fig
top
panel
fig
appear
decreas
later
time
point
also
observ
alphavirus
appar
decreas
probabl
due
degrad
minu
strand
least
partli
due
hamper
detect
caus
larg
excess
positivestrand
rna
present
late
time
point
excess
positivestrand
rna
compet
radioact
label
minusstrand
specif
probe
support
observ
mix
rna
isol
chikvinfect
cell
h
pi
vitro
transcrib
positivestrand
rna
reduc
amount
neg
strand
could
detect
data
shown
furthermor
sampl
taken
h
pi
treat
singlestrandspecif
rnase
hybrid
negativestrand
level
late
time
point
approxim
h
pi
instead
approxim
untreat
sampl
data
shown
use
positivestrandspecif
probe
genom
sgrna
could
detect
rna
accumul
h
pi
fig
middl
panel
fig
ratio
genom
sgrna
vari
cours
infect
similar
ratio
report
semliki
forest
viru
sinv
kinet
rna
synthesi
rna
accumul
level
similar
chikv
cell
cell
infect
chikv
addit
subgenom
rna
encod
egfp
report
gave
rise
extra
band
rna
band
express
level
calcul
approxim
half
rna
individu
level
two
sgrna
express
chikv
lower
combin
abund
compar
virus
express
singl
sgrna
fig
monitor
viral
protein
express
cell
infect
chikv
total
protein
isol
variou
time
point
post
infect
sampl
analyz
western
blot
antisera
nonstructur
protein
structur
protein
express
precursor
could
detect
earli
h
pi
protein
accumul
time
reach
plateau
around
h
pi
fig
rdrp
could
detect
infect
cell
use
chikv
antiserum
capabl
detect
purifi
bacteri
express
protein
probabl
due
low
affin
antibodi
low
express
level
rel
instabl
infect
cell
also
observ
alphavirus
addit
quantit
proteom
studi
chikvinfect
cell
also
suggest
h
pi
amount
least
lower
treffer
ta
de
ru
van
veelen
snijder
van
hemert
manuscript
prepar
indirect
immunofluoresc
analysi
vero
cell
infect
chikv
variou
time
point
show
local
express
kinet
dsrna
similar
natur
isol
synthet
virus
fig
doublestrand
rna
assum
gener
replic
chikv
infect
cell
could
detect
earli
h
pi
remain
clearli
visibl
throughout
infect
dsrna
local
foci
throughout
cytoplasm
protein
could
detect
h
pi
onward
maximum
express
reach
h
pi
protein
mainli
local
plasma
membran
infect
cell
egfp
produc
report
viru
visibl
h
pi
onward
reach
maximum
level
around
h
pi
fig
chikv
compar
neutral
assay
use
neutral
monoclon
antibodi
rais
mice
chikv
virion
appear
recogn
linear
epitop
nonneutr
mab
use
control
natur
isol
chikv
neutral
similar
characterist
infect
affect
fig
newborn
mice
highli
suscept
chikv
infect
develop
symptom
lethargi
drag
hind
limb
flaccid
paralysi
reduc
weight
gain
old
mice
inject
intraperiton
chikv
prototyp
strain
control
anim
euthan
human
end
point
reach
day
post
infect
viral
rna
level
brain
tissu
analyz
fig
synthet
virus
behav
like
natur
isol
vivo
caus
lethal
infect
similar
kinet
fig
addit
viral
titer
brain
chikv
mice
similar
mice
infect
synthet
virus
fig
evalu
suitabl
analyz
potenc
mechan
action
antivir
compound
sensit
chikv
number
compound
determin
compar
cyclosporin
effect
cellular
cyclophilin
inhibit
replic
varieti
virus
specif
effect
chikv
replic
even
cytotox
dose
data
shown
compound
chloroquin
mycophenol
acid
test
cpe
reduct
assay
vero
cell
infect
moi
analyz
day
pi
found
inhibit
chikv
replic
low
micromolar
rang
minim
cytotox
fig
substanti
differ
observ
valu
calcul
four
compound
also
clearli
reduc
egfp
report
gene
express
vero
cell
infect
chikv
fig
slightli
lower
valu
obtain
chloroquin
significantli
higher
observ
assay
compar
cpebas
assay
might
due
mode
action
andor
due
differ
experiment
setup
compar
cpebas
assay
moi
vs
measur
h
pi
vs
pi
ribavirin
known
inhibitor
chikv
replic
cpe
reduct
assay
vero
cell
effect
inhibit
replic
variou
strain
valu
obtain
fig
gray
line
like
due
ineffici
convers
ribavirin
activ
phosphoryl
form
vero
cell
therefor
also
analyz
effect
ribavirin
cpe
reduct
assay
cell
abl
metabol
ribavirin
found
variou
strain
clinic
isol
also
includ
assay
appear
somewhat
sensit
antivir
compound
howev
slower
replic
kinet
strain
made
imposs
directli
compar
cpe
reduct
assay
despit
fact
viru
yield
cytopath
effect
compar
data
shown
massiv
chikv
outbreak
occur
asia
indian
ocean
region
sinc
associ
emerg
strain
substitut
glycoprotein
allow
transmiss
novel
mosquito
vector
aed
albopictu
eastcentralsouth
african
lineagederiv
strain
even
appear
replac
asian
lineag
chikv
strain
endem
region
decad
sinc
geograph
distribut
aed
albopictu
dramat
expand
also
includ
larg
part
usa
sever
european
countri
creat
concern
local
transmit
outbreak
europ
usa
could
initi
viraem
travel
arriv
countri
chikv
endem
like
india
indonesia
local
transmit
chikv
infect
inde
alreadi
report
itali
franc
recent
studi
suggest
also
usa
risk
local
transmit
chikv
outbreak
besid
larg
medic
societ
impact
endem
countri
increas
risk
chikv
outbreak
europ
usa
underlin
import
studi
replic
import
human
pathogen
interact
host
develop
safe
effect
vaccin
antivir
therapi
infecti
cdna
clone
proven
import
tool
studi
mani
aspect
viral
life
cycl
molecular
clone
varieti
natur
isol
instrument
sever
recent
chikv
studi
exist
chikv
molecular
clone
consid
deriv
singl
genom
fragment
singl
genom
whole
spectrum
virus
present
chikv
quasispeci
popul
contrast
complet
chikv
genom
sequenc
deposit
genbank
repres
consensu
master
sequenc
viral
quasispeci
popul
divers
evolut
chikv
quasispeci
popul
probabl
shape
characterist
individu
host
specif
tissu
sourc
serum
isol
ross
river
viru
observ
level
intrahost
genet
variat
patient
serum
sampl
consider
larger
observ
epidemiolog
scale
explain
purifi
select
replic
arthropod
vertebr
host
advanc
sequenc
techniqu
allow
detail
view
quasispeci
divers
intrahost
evolut
also
chikv
recent
studi
provid
insight
quasispeci
dynam
effect
purifi
select
host
altern
link
observ
increas
fit
result
altern
passag
reduc
quasispeci
complex
restrict
adapt
novel
select
pressur
like
antivir
treatment
antibodymedi
neutral
individu
chikv
isol
molecular
clone
deriv
virus
could
specif
properti
term
replic
kinet
vector
specif
dissemin
within
host
virul
virushost
interact
sensit
antivir
compound
interest
studi
gener
characterist
life
cycl
virushost
interact
chikv
strain
circul
outbreak
therefor
construct
fulli
synthet
cdna
clone
chikv
base
consensu
sequenc
align
genom
recent
isol
rather
singl
genom
clinic
isol
addit
variant
express
egfp
report
gene
control
duplic
subgenom
promot
creat
chikv
current
possibl
gene
synthesi
allow
design
clone
silico
sequenc
tailor
requir
eg
alreadi
contain
report
gene
control
duplic
subgenom
promot
includ
translat
silent
mutat
creat
restrict
site
facilit
clone
revers
genet
studi
align
complet
chikv
genom
genbank
june
yield
consensu
sequenc
differ
nucleotid
posit
sequenc
design
year
earlier
posit
introduc
translat
silent
restrict
site
synonym
substitut
posit
posit
c
deposit
genom
strain
remain
strain
u
posit
interest
observ
sequenc
chikv
strain
includ
prototyp
strain
ross
contain
arginin
codon
instead
opal
stop
codon
present
region
chikv
isol
presenc
absenc
opal
codon
might
influenc
passag
histori
isol
observ
alphavirus
might
also
explain
sequenc
origin
clinic
isol
genbank
contain
opal
termin
codon
near
end
code
region
infecti
clone
strain
genbank
contain
arginin
codon
posit
assess
whether
synthet
virus
repres
model
characterist
compar
natur
strain
like
natur
isol
synthet
virus
caus
cytopath
infect
vero
cell
fig
wherea
noncytopath
persist
infect
observ
mosquito
cell
line
vertebr
cell
strain
caus
shutoff
cellular
translat
around
h
pi
strong
inhibit
cellular
transcript
h
pi
accumul
neg
positivestrand
viral
rna
kinet
nonstructur
structur
viral
protein
express
well
growth
kinet
plaqu
morpholog
synthet
virus
indistinguish
chikv
fig
addit
synthet
virus
caus
lethal
infect
old
mice
viru
spread
brain
observ
natur
isol
fig
although
demonstr
synthet
virus
replic
vivo
mous
model
allow
comparison
strain
subtl
differ
virul
pathogenesi
genom
stabil
chikv
assess
passag
consensu
sequenc
found
ident
origin
silico
design
sequenc
express
egfp
report
gene
stabl
least
passag
make
synthet
virus
suitabl
tool
highthroughput
screen
antivir
compound
revers
genet
studi
mechan
action
systemat
function
genom
screen
host
factor
affect
chikv
replic
evalu
whether
chikv
suitabl
analyz
potenc
mechan
action
antivir
compound
sensit
number
compound
determin
compar
lysosomotrop
agent
chloroquin
nucleosid
analog
inhibit
replic
synthet
virus
natur
isol
rang
compar
valu
previous
report
other
inhibitori
effect
chloroquin
replic
mani
virus
includ
alphavirus
known
decad
chikv
use
refer
compound
cellbas
studi
small
scale
clinic
trial
island
la
reunion
suggest
effect
treatment
chikv
infect
patient
nucleosid
analog
previous
report
inhibit
replic
varieti
virus
includ
chikv
compound
could
interfer
cellular
utp
metabol
may
incorpor
chikv
rna
lead
chain
termin
andor
increas
error
frequenc
ultim
result
error
catastroph
mycophenol
acid
noncompetit
inhibitor
inosin
monophosph
dehydrogenas
impdh
caus
deplet
intracellular
guanosin
pool
known
inhibitor
variou
virus
includ
chikv
ribavirin
synthet
nucleosid
analog
broad
spectrum
antivir
effect
due
potenti
effect
cellular
impdh
enzym
viral
rna
synthesi
cap
howev
cell
line
abl
perform
necessari
convers
compound
activ
phosphoryl
form
explain
contradictori
report
antivir
activ
compound
hand
ribavirin
inhibit
chikv
replic
cell
around
hardli
effect
vero
cell
valu
obtain
cell
rang
previous
report
antivir
effect
ribavirin
chikv
replic
cyclosporin
effect
cellular
cyclophilin
inhibit
replic
varieti
virus
recent
review
see
effect
chikv
replic
identifi
novel
inhibitor
chikv
replic
approxim
compound
previous
identifi
inhibitor
broad
spectrum
virus
although
mani
rna
virus
appear
rather
insensit
affect
review
antivir
activ
attribut
inhibitori
effect
cellular
enzym
sadenosylhomocystein
hydrolas
lead
accumul
sadenosylhomocystein
inhibit
sadenosylmethioninedepend
methyl
reaction
manner
enzym
play
key
role
sadenosylmethioninedepend
methyl
reaction
inhibit
viral
methyl
reaction
eg
viral
rna
appar
achiev
compound
concentr
notabl
interfer
cellular
methyl
reaction
observ
warrant
detail
analysi
mode
action
analog
also
evalu
potenti
use
antivir
therapi
treat
chikv
infect
overal
larg
differ
observ
valu
calcul
indic
synthet
virus
suitabl
use
antivir
screen
compound
faster
simpler
assay
chikv
report
viru
show
good
dosedepend
respons
correl
well
result
obtain
cpebas
assay
clinic
isol
exhibit
slightli
slower
replic
kinet
appear
sensit
antivir
compound
synthet
virus
differ
sensit
antivir
compound
among
clinic
isol
uncommon
phenomenon
differ
amino
acid
posit
interest
determin
contribut
mutat
particular
substitut
slower
replic
kinet
higher
sensit
antivir
taken
togeth
detail
character
chikv
replic
cycl
molecular
level
demonstr
new
synthet
consensusbas
virus
behav
like
natur
isol
suitabl
tool
studi
variou
aspect
chikv
life
cycl
ultim
provid
basi
develop
antivir
therapi
